BioWorld MedTech

July 6, 2017

Edwards wins FDA approval for resilient heart valve device

Edwards Lifesciences Corp. received FDA approval for its Inspiris Resilia aortic valve. The Irvine, Calif.-based company said the valve is resistant to calcification, and leads the way for a new class of resilient heart valve devices. Read More

Fingerstick-free, disposable CGMs (and more) are on the way, but when?

NICE sees economics of Abbott's Freestyle Libre CGM as 'uncertain'

U.K. industry leaders encouraged by ministers' stance on post-Brexit drug/device regulation

U.S. stent makers view India price caps with suspicion

Other news to note

Financings

Daily M&A

Product briefs

Regulatory front

BioWorld MedTech's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 10, 2025.

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026